Axabin 2.5®

Brand name: Arena Life Science

Generic Name: Rivaroxaban

Rivaroxaban is a highly selective direct factor Xa inhibitor with high oral bioavailability. Inhibition of factor Xa interrupts the intrinsic and extrinsic pathway of the blood coagulation cascade, inhibiting both thrombin formation and development of thrombi.

Pharmaceutical Class: Anticoagulant

Dosage Form and Strength: Oral Film-coated tablet, 2.5 mg

Product Description:

INDICATIONS

  •  Axabin 2.5mg, co-administered with low dose Aspirin (75– 100 mg) alone or with ASA plus clopidogrel, is indicated for the prevention of atherothrombotic events in adult patients after an acute coronary syndrome (ACS) with elevated cardiac biomarkers
  •  Axabin 2.5mg, co-administered with low dose Aspirin (75– 100 mg), is indicated for the prevention of atherothrombotic events in adult patients with coronary artery disease (CAD) or symptomatic peripheral artery disease (PAD) at high risk of ischemic events.
  • Axabin® is the first generic form of rivaroxaban in Iran which is produced at a GMP approved manufacturing site

Additional Information

Additional information

Related Products

Axabin 2.5®

View Product

Product Images

axabin11-4 axabin11-3 axabin11-2